Cargando…
Covid-19 and lung cancer: A greater fatality rate?
BACKGROUND: Currently there are no reported series determining the Covid-19 infected lung cancer patient´s characteristics and outcome that allow us to clarify strategies to protect our patients. In our study we determine whether exists differences in cumulative incidence and severity of Covid-19 in...
Autores principales: | Rogado, Jacobo, Pangua, Cristina, Serrano-Montero, Gloria, Obispo, Berta, Marino, Almudena Martín, Pérez-Pérez, Mar, López-Alfonso, Ana, Gullón, Pedro, Lara, Miguel Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260554/ https://www.ncbi.nlm.nih.gov/pubmed/32505076 http://dx.doi.org/10.1016/j.lungcan.2020.05.034 |
Ejemplares similares
-
COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020) -
Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020) -
Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022) -
Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022) -
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors
por: Rogado, Jacobo, et al.
Publicado: (2021)